menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Stada reschedules IPO due to market volatility, sources say

    REUTERS

    Stada Reports Strong Earnings, CEO Tempers Sale And IPO Expectations

    FIERCE PHARMA

    STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In EU

    GLOBENEWSWIRE

    Alvotech and STADA add to strategic alliance through denosumab partnership

    PRESS RELEASE

    Calliditas Partner STADA Gets CHMP Nod For Kinpeygo In IgA Nephropathy

    PR NEWSWIRE

    iTeos to raise $120M; Xbrane and STADA to out-license Lucentis biosimilar

    ENDPTS

    STADA and Alvotech Secure Approval for Uzpruvo

    GLOBENEWSWIRE

    Germany`s Stada has spun off Russian business - newspaper

    REUTERS

    STADA and Alvotech receive positive CHMP opinion for ustekinumab biosimilar

    GLOBENEWSWIRE

    STADA & Calliditas announce filing for full marketing authorization of Kinpeygo

    PR NEWSWIRE

    Stada`s Kinpeygo (budesonide) Receives Approval in Europe

    EMA

    Stada in `exploratory` phase of potential sale: CEO

    FIERCE PHARMA

    Stada`s Kinpeygo (budesonide) Receives Approval in Europe

    EMA

    Stada is acquiring additional brands from Sanofi

    PRESS RELEASE

    STADA Arzneimittel`s Ximluci (Ranibizumab) Receives Approval in Europe

    EMA

    STADA announces US FDA approves Norbitec biotech facility in Uetersen

    PHARMABIZ

    Advent, CVC Are Among Suitors for €3 Billion Viatris OTC Assets

    BLOOMBERG

    EMA Confirms Acceptance of Application for AVT04, Proposed Biosimilar to Stelara

    STADA

    STADA, Xbrane get UK MHRA marketing approval for Ximluci biosimilar Lucentis

    PHARMABIZ

    Stada appoints Boris Döbler as chief financial officer

    PHARMABIZ

    With boost from Romania, Stada breaks ground on $50M plant

    FIERCEPHARMA

    Stada to place $50M+ investment in a new facility in Romania

    ENDPTS

    Stada`s Kinpeygo (budesonide) Receives Approval in the Europe

    EMA

    Stada and Xbrane gain EU approval for biosimilar Ximluci

    PHARMATIMES

    Stada Arzneimittel`s Hukyndra (adalimumab) Receives Approval in the Europe

    EMA

    Alvotech, Stada introduce Hukyndra, a biosimilar to adalimumab in Switzerland

    PHARMABIZ

    Alvotech and STADA Increase Access to Adalimumab for Patients in Switzerland

    GLOBENEWSWIRE

    Stada introduces Kinpeygo in European markets to treat primary IgA nephropathy

    PHARMABIZ

    Calliditas` partner STADA launches the first medicine authorized in the EU

    PRNEWSWIRE

    STADA and Xbrane welcome EMA positive opinion for ranibizumab biosimilar

    STADA

    STADA and Alvotech broaden European patients’ options by launching Hukyndra

    BUSINESSWIRE

    Teva launches Revlimid generic, the first to do so in U.S.

    FIERCEPHARMA

    Sandoz launches generic oncology treatment in Europe

    PMLIVE

    Crescita Therapeutics and STADA Enter Exclusive Licensing Agreement for Pliaglis

    BUSINESSWIRE

    STADA & Sanofi strike consumer healthcare distribution agreement in EU

    PRESSEPORTAL

    STADA & Sanofi strike consumer healthcare distribution agreement in EU

    PRESSEPORTAL

    STADA and Midas Pharma: Driving procurement forward together

    PRESS RELEASE

    STADA and PharmaMar sign agreement to commercialize Yondelis®

    ZAWYA

    European Company STADA enters exclusive Medical Partnership MediPharm Labs

    STADA

    STADA expands specialty footprint through acquisition of innovative therapy

    PRESSRELEASE

    STADA expands specialty footprint through acquisition of innovative therapy

    PRESS RELEASE

    STADA‘s US partner Supernus submits NDA for apomorphine infusion pump

    PRESS RELEASE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.